SCHEMBL10319230

SCHEMBL10319230

COC(=O)c1ccc(C)c(NC(=O)c2cc3ccccc3[nH]c2=O)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 4/20 0.74
▸ DYRK1B Q9Y463 3/20 0.74
▸ MAPK14 Q16539 1/20 0.47
▸ PARP1 P09874 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ LMNA P02545 2/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ MAOA P21397 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ SMYD3 Q9H7B4 1/20 0.44
▸ POLB P06746 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ NPY1R P25929 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ NPY2R P49146 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11950311 0.89 DYRK1A (0.59) DYRK1ADYRK1BMAPK14PARP1TSHR
SCHEMBL10318281 0.85 DYRK1A (1.00) DYRK1ADYRK1BMAPK14LMNAMAPT
SCHEMBL21639567 0.84 EGFR (0.54) DYRK1ADYRK1BL3MBTL1LMNARXFP1
SCHEMBL10321271 0.81 DYRK1A (0.72) DYRK1ADYRK1BMAPK14LMNAMAPT
SCHEMBL10321365 0.81 DYRK1A (0.80) DYRK1ADYRK1BMAPK14TSHRL3MBTL1
SCHEMBL10322269 0.80 DYRK1A (0.72) DYRK1ADYRK1BMAPK14TSHRLMNA
SCHEMBL10318061 0.78 DYRK1A (0.85) DYRK1ADYRK1BMAPK14MAPTKDM4E
SCHEMBL10317577 0.78 DYRK1A (0.85) DYRK1ADYRK1BMAPK14MAPTKDM4E
SCHEMBL10324364 0.78 DYRK1A (1.00) DYRK1ADYRK1B
SCHEMBL3632228 0.78 PADI4 (0.56) PARP1TSHRL3MBTL1LMNARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012098070-A1 QUINOLINE DYRK1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES DOMINIQUE ROMYR (US) 2012-07-19 — — US disclosed
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES DOMINIQUE ROMYR (US) 2012-07-19 — — US disclosed
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES DOMINIQUE ROMYR (US) 2012-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES GOT1, PPARG, PPARA DYRK1A 2480/4885DYRK1B 3023/4885MAPK14 1729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback